News and insights
At Johnson & Johnson, we are building a world where complex diseases are prevented, treated and cured. Where treatments are smarter and less invasive—and solutions are personal.
Discover our most recent updates, learn about groundbreaking innovations and meet some of the dedicated individuals who make it all happen.
Discover our most recent updates, learn about groundbreaking innovations and meet some of the dedicated individuals who make it all happen.
-
What you need to know about Johnson & Johnson’s second-quarter 2026 earnings report
Check out this infographic breakdown of the company’s second-quarter performance, with highlights from its Innovative Medicine and MedTech businesses. -
Patients share what it’s like to have wAIHA, a disease that causes the immune system to destroy red blood cells
Warm autoimmune hemolytic anemia is a rare, life-threatening disease that causes intense fatigue. Johnson & Johnson has a new therapy that targets the underlying drivers of the disease. Here, two patients—and Johnson & Johnson employees—share their journey, from symptoms and diagnosis to managing work and personal life.
-
The Johnson & Johnson Institute helps HCPs learn new surgery skills—here’s how
From suturing to robotics system training, the Johnson & Johnson Institute is bringing surgical education to busy HCPs so they can deliver safe, effective care. -
5 things we now know about prostate cancer
This disease is highly treatable if caught early—but in its earliest stages, prostate cancer often has no symptoms, allowing it to develop without detection. Learn more about this common cancer and how Johnson & Johnson is innovating across both early-stage and advanced disease.
More from Johnson & Johnson
When depression improves but patients still grapple with symptoms
Only one in three people with major depressive disorder achieves remission after their first antidepressant, leaving many to continue to experience life-impacting symptoms such as disrupted sleep, changes in weight and appetite and trouble concentrating. Learn why Johnson & Johnson is working to help more patients achieve remission.
“We are in a golden age of cataract surgery”
Once considered a straightforward procedure to restore cloudy vision, cataract surgery has evolved into one of the most technologically advanced—and personalized—operations in modern medicine. Learn how Johnson & Johnson’s 25-year history of innovation is helping eye surgeons meet the moment.
What is acute myeloid leukemia?
It’s the most common type of acute leukemia in adults, yet it has the lowest survival rate of all leukemias. Learn more about this difficult-to-treat blood cancer and why Johnson & Johnson is on a mission to deliver better treatment options.
The IBD resource many patients say they can’t live without
Inflammatory bowel disease (IBD) is often described as an “invisible illness” due to symptoms that aren’t always apparent to others. But for the millions living with the disease, the impact goes beyond physical symptoms. Learn how Johnson & Johnson is helping create a patient community for those dealing with the heavy psychological toll of IBD.
Johnson & Johnson named to The Wall Street Journal’s 2026 Best Companies for the Future list
The company’s ability to evolve as it tackles the world’s toughest health challenges has helped Johnson & Johnson earn its spot as the top-ranked healthcare company on the list.